Senior insider sale
SVP, Finance at ALLOGENE THERAPEUTICS, INC. — senior position signals high conviction
$22.1K
9.59K shares
What this filing means
YOSHIYAMA ANNIE plans to sell 9.59K shares of ALLOGENE THERAPEUTICS, INC. valued at approximately $22.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/22/2026ACC: 0001835208-26-000001
Officer· SVP, Finance
Since Feb 2026
9.59K
Shares to sell
$22.1K
Approx. market value
9.59K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Vesting of restricted stock unit award
Granted as part of issuer equity compensation plan
4/20/2026
9.59KTotal acquired9.59K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/20/2026 | Vesting of restricted stock unit award Granted as part of issuer equity compensation plan | 9.59K | — |
| Total | 9.59K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
9.59K
Market value
$22.1K
4/21/2026
Total
Units
9.59K
Value
$22.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
4/21/2026 | 9.59K | $22.1K | NASDAQ | Planned |
| Total | 9.59K | $22.1K | ||